Kontakt

Můžete nás kontaktovat:

Emailem:  czech_republic@lundbeck.com / Telefonicky: +420 225 275 600

Kontaktujte naši compliance hotline

Stránka Compliance Hotline

Hlášení nežádoucích příhod

Nahlašte zde...

Have Questions?

Get in Touch

Contact Us

Naše zastoupení

Argentina Subsidiary Lundbeck Argentina S.A.
Heredia 553
C1427CNG
Ciudad Autónoma de Buenos Aires
Argentina 		Tel. +54 11 4553 7800
Fax: +54 11 4836 3363
argentina@lundbeck.com
www.lundbeck.com/ar 		Kontakt
Australia Subsidiary Lundbeck Australia Pty Ltd
1 Innovation Road
North Ryde
NSW 2113
Australia 		Tel. +61 2 8669 1000
Fax: +61 2 8669 1090
australia@lundbeck.com
www.lundbeck.com/au 		Kontakt
Austria Subsidiary Lundbeck Austria GmbH
Spaces Square One
Leopold Ungar Platz 2
1190
Vienna
Austria 		Tel. +43 1 253 621 6033
Fax: +43 1 253 3033 1733
austria@lundbeck.com
www.lundbeck.com/at 		Kontakt
Belgium Subsidiary Lundbeck N.V./S.A.
Stephanie Square Centre
Louizalaan/Avenue Louise 65
Box 11
1050
Brussel/Bruxelles
Belgium 		Tel. +32 2 535 79 79
belgium@lundbeck.com
www.lundbeck.com/be 		Kontakt
Brazil Subsidiary Lundbeck Brasil Ltda.
CNPJ: 04.522.600/0001-70
Av. João Cabral de Mello Neto, 400/1201
Barra da Tijuca
RJ 22.775-057
Rio de Janeiro
Brazil 		Tel. +55 21 3873 3000
brazil@lundbeck.com
www.lundbeck.com/br 		Kontakt
Bulgaria Rep office Lundbeck Export A/S
EXPO 2000
55 N. Vaptzarov Blvd.
1407
Sofia
Bulgaria 		Tel. +359 2 962 4696
Fax: +359 2 962 5480
bulgaria@lundbeck.com
www.lundbeck.com/bg 		Kontakt
Canada Subsidiary Lundbeck Canada Inc.
2600 Alfred-Nobel boulevard
Suite 400
Ville Saint-Laurent
H4S 0A9
Montréal Québec
Canada 		Tel. +1 514 844 8515
Fax: +1 514 844 5495
canada@lundbeck.com
www.lundbeck.com/ca/en 		Kontakt
Chile Subsidiary Lundbeck Chile Farmacéutica Ltda.
Av. Vitacura 5250
Of. 401 Vitacura
7630225
Santiago
Chile 		Tel. +56 2 29 53 85 00
Fax: +56 2 29 53 85 85
chile@lundbeck.com
www.lundbeck.com/cl 		Kontakt

Více z Lundbecku

Investor Relations 

Detailed information related to Lundbeck’s financial performance. Contact Palle Olesen, VP, Investor Relations:
+ 45 3083 2426 

About Us 

A global pharmaceutical company specialized in brain diseases.

Press

For general press enquiries, please call + 45 3643 4000

Poslední aktualizace: 1.GMTáří 2023